12:00 AM
Nov 02, 2009
 |  BC Week In Review  |  Company News  |  Other News

Amgen hematology news

Fourteen states and the District of Columbia filed suit against Amgen in the U.S. District Court for the District of Massachusetts alleging the biotech offered kickbacks to medical providers to increase sales of its anemia drug Aranesp darbepoetin alfa. The plaintiffs allege that Amgen offered kickbacks to medical...

Read the full 226 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >